Underuse of Oral Anticoagulants in Privately Insured Patients with Atrial Fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to ImProve treatment with Oral AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AFib)

Several members of DiMe's leadership participated in a study, published in the American Heart Journal, concludes that there is an unmet need for evidence-based interventions that could lead to greater use of OACs in patients with AF at risk for stroke.

July 2020 in American Heart Journal

BioMeT and Algorithm Challenges: A Proposed Digital Standardized Evaluation Framework

DiMe members and colleagues offer pragmatic guidance regarding BioMeTs, culminating in a proposed framework to advance their development and deployment in healthcare, health research, and health promotion. The framework proposes a process to establish an audit trail of BioMeTs.

May 2020 in IEEE Journal of Translational Engineering in Health and Medicine

Page 1 of 5